[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [Vaxcyte, Inc. Common Stock](/topic/$pcvx) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "52 Week Losers - US Stocks by Yahoo Finance: $LYTHF Lytus PTV $SRPT Sarepta Therapeutics $GLOB Globant S A $GTOFF PT GoTo Gojek Tokopedia Tbk $CE Celanese $MNRIF Minor Public $PCVX Vaxcyte $VG Venture Global $FRPT Freshpet $INSP Inspire Medical Systems $ENPH Enphase Energy $DOW Dow $TTD Trade Desk $ANF Abercrombie & Fitch $FLY Firefly Aerospace #StockInFocus" [X Link](https://x.com/aipatternlab/status/1979623546990088565) [@aipatternlab](/creator/x/aipatternlab) 2025-10-18T19:00Z 4270 followers, XXX engagements "October 16th 2025 Daily Update Markets go weeeeeeeeeeeeeeee portfolio comes back into the 70s after all but $RARE is red today. $RARE (and $PCVX to an extent) showed the most resilience. Again these are names that I think are likely to have high institutional interest and have not experienced the same run as some of the others. So not entirely surprised to see that" [X Link](https://x.com/medstudentinvst/status/1978918054227775740) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-16T20:16Z XXX followers, XXX engagements "$PCVX continues to inch-up. They still have data to show of course. However in my personal view it was an absolute steal a steal to be able to get this in the 30's for a company as large it is with such a strong a cash position. Surprised it took as long as it did to see some of the sector gains biotech in general has seen especially after NIH made its vaccine position abundantly clear. $RARE is also inching up. Setrusumab is still an open question and is by no means guaranteed. However from a risk-reward perspective given downside is protected by the commercial business and has two other" [X Link](https://x.com/medstudentinvst/status/1978487036764934419) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-15T15:44Z XXX followers, XXX engagements "Top Post-Market Movers (Post-market %) $TAC TransAlta (+7.53%) $BTSG BrightSpring Health Services (+6.62%) $FLNC Fluence Energy (+5.42%) $BTDR Bitdeer Technologies (+3.78%) $ALAB Altaba (+3.68%) $ADM Archer-Daniels-Midland (+3.12%) $YPF YPF (+3.07%) $CMA Comerica (5.71%) $PCVX Vaxcyte (6.44%)" [X Link](https://x.com/tradedots/status/1978309093283820005) [@tradedots](/creator/x/tradedots) 2025-10-15T03:56Z 1165 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"52 Week Losers - US Stocks by Yahoo Finance: $LYTHF Lytus PTV $SRPT Sarepta Therapeutics $GLOB Globant S A $GTOFF PT GoTo Gojek Tokopedia Tbk $CE Celanese $MNRIF Minor Public $PCVX Vaxcyte $VG Venture Global $FRPT Freshpet $INSP Inspire Medical Systems $ENPH Enphase Energy $DOW Dow $TTD Trade Desk $ANF Abercrombie & Fitch $FLY Firefly Aerospace #StockInFocus"
X Link @aipatternlab 2025-10-18T19:00Z 4270 followers, XXX engagements
"October 16th 2025 Daily Update Markets go weeeeeeeeeeeeeeee portfolio comes back into the 70s after all but $RARE is red today. $RARE (and $PCVX to an extent) showed the most resilience. Again these are names that I think are likely to have high institutional interest and have not experienced the same run as some of the others. So not entirely surprised to see that"
X Link @medstudentinvst 2025-10-16T20:16Z XXX followers, XXX engagements
"$PCVX continues to inch-up. They still have data to show of course. However in my personal view it was an absolute steal a steal to be able to get this in the 30's for a company as large it is with such a strong a cash position. Surprised it took as long as it did to see some of the sector gains biotech in general has seen especially after NIH made its vaccine position abundantly clear. $RARE is also inching up. Setrusumab is still an open question and is by no means guaranteed. However from a risk-reward perspective given downside is protected by the commercial business and has two other"
X Link @medstudentinvst 2025-10-15T15:44Z XXX followers, XXX engagements
"Top Post-Market Movers (Post-market %) $TAC TransAlta (+7.53%) $BTSG BrightSpring Health Services (+6.62%) $FLNC Fluence Energy (+5.42%) $BTDR Bitdeer Technologies (+3.78%) $ALAB Altaba (+3.68%) $ADM Archer-Daniels-Midland (+3.12%) $YPF YPF (+3.07%) $CMA Comerica (5.71%) $PCVX Vaxcyte (6.44%)"
X Link @tradedots 2025-10-15T03:56Z 1165 followers, XXX engagements
/topic/$pcvx/posts